Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1547)	2/11/1999 9:16:00 PM
From: Anthony@Pacific	Respond to of 2135

ENMD<---------DOW JONES STORY !!! 16 ;18 pst " BRistol Myers Abandons role with ENMD", " The Protein in its present form does d not meet Bristol's Criteria for moilecules that advance to clinical trials.", According to the filings and the news there is zero Commercial viability currently with ENMD..ISNT THAT as OBVIOUS as the nose on your face??????? People can be so dumb and only at that one fateful moment they realize that they are clueless do they "get it".. ENMD is going to cost shareholders lots of money if you dont sell at this level...It isnt going to get more financially viable tomorrow or the next day..Its all down hill after tomorrow morning..